39
Views
4
CrossRef citations to date
0
Altmetric
Special Report

Effects of nCPAP therapy on cardiorespiratory outcomes in obstructive sleep apnea syndrome: compliance and technological advancements

, &
Pages 41-47 | Published online: 09 Jan 2014

References

  • Toraldo DM, Nicolardi G, De Nuccio F. Effects of nCPAP treatment on quality of life of patients with obstructive sleep apnoea syndrome. Eur. Respir. J.28(Suppl.), 50, 410s (2006).
  • Lavie P. Mortality in sleep apnoea syndrome: a review of the evidence. Eur. Respir. Rev.16(106), 203–210 (2007).
  • Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnoea syndrome. Chest127(6), 2076–2084 (2005).
  • Lavie P, Herer P, Lavie L. Mortality risk factors in sleep apnoea: a matched case-control study. J. Sleep Res.16(1), 128–134 (2007).
  • Alonso-Fernández A, García-Río F, Arias MA et al. Effects of nCPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax64(7), 581–586 (2009).
  • Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI. Molecular signatures of obstructive sleep apnea in adult: a review and perspective. Sleep32(4), 447–470 (2009).
  • Steiropoulos P, Kotsianidis I, Nena E et al. Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep32(4), 537–543 (2009).
  • Jordan W, Cohrs S, Degner D et al. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J. Neural. Transm.113(2), 239–254 (2006).
  • Lam JC, Ip MS. An update on obstructive sleep apnea and the metabolic syndrome. Curr. Opin. Pulm. Med.13(6), 484–489 (2007).
  • McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am. J. Respir. Crit. Care Med.175(2), 190–195 (2007).
  • Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet373(9657), 82–93 (2009).
  • Tamaki S, Yamauchi M, Fukuoka A et al. Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome. Intern. Med.48(15), 1255–1262 (2009).
  • Steiropoulos P, Tsara V, Nena E et al. Effect of continuous positive airway on serum effect of continuous positive airway cardiovascular risk factors in patient’s obstructive sleep apnoea–hypopnoea syndrome. Chest132(3), 843–851 (2007).
  • Kohler M, Pepperell JC, Casadei B et al. CPAP and measures of cardiovascular risk in males with OSAHS. Eur. Respir. J.32(6), 1488–1496 (2008).
  • Minoguchi K, Yokoe T, Tanaka A et al. Association between lipid peroxidation and inflammation in obstructive sleep apnea. Eur. Respir. J.28(2), 378–385 (2006).
  • Martínez-García MA, Soler-Cataluña J, Ejarque-Martínez L et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am. J. Respir. Crit. Care Med.180(1), 36–41 (2009).
  • Bassetti CL, Milanova M, Stroke GM. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke37(4), 967–972 (2006).
  • Mokhlesi B, Tulaimat A, Evans AT et al. Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnoea. J. Clin. Sleep Med.2(1), 57–62 (2006).
  • Bardwell WA, Norman D, Ancoli-Israel S et al. Effects of 2-week nocturnal oxygen supplementation and continuous positive airway pressure treatment on psychological symptoms in patients with obstructive sleep apnoea: a randomized placebo-controlled study. Behav. Sleep Med.5(1), 21–38 (2007).
  • Hernández C, Abreu J, Abreu P, Castro A, Jiménez A. Nocturnal melatonin plasma levels in patients with OSAS: the effect of NCPAP. Eur. Respir. J.30(3), 496–500 (2007).
  • Gay P, Weaver T, Loube D et al. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep29(3), 381–404 (2006).
  • Zimmerman ME, Arnedt JT, Stanchina M, Millman RP, Aloia MS. Normalization of memory performance and positive airway pressure adherence in memory-impaired patients with obstructive sleep apnea. Chest130(6), 1772–1778 (2006).
  • Matsuo A, Inoue Y, Namba K, Chiba H. Changes in cerebral hemoglobin indices in obstructive sleep apnea syndrome with nasal continuous positive airway pressure treatment. Sleep Breath. DOI: 10.1007/s11325–010–0367-y (2010) (Epub ahead of print).
  • Kribbs NB, Pack AI, Kline LR et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am. Rev. Respir. Dis.147(4), 887–895(1993).
  • Jean Wiese H, Boethel C, Phillips B, Wilson JF, Peters J, Viggiano T. CPAP compliance: video education may help! Sleep Med.6(2), 171–174 (2005).
  • Mc Ardle N, Devereux G, Heidarnejad H et al. Long term use of CPAP therapy for Sleep apnea/hypopnoea syndrome. Am. J. Respir. Crit. Care Med.159(4 Pt 1), 1108–1114 (1999).
  • Yetkin O, Kunter E, Gunen H. nCPAP compliance in patients with obstructive sleep apnea syndrome. Sleep Breath.12(4), 365–367 (2008).
  • Sugiura T, Noda A, Nakata S et al. Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome. Respiration74(1), 56–60 (2007).
  • Richards D, Bartlett DJ, Wong K, Malouff J, Grunstein RR. Increased adherence to CPAP with a group cognitive behavioural treatment intervention: a randomized trial. Sleep30(5), 635–640 (2007).
  • Wells RD, Freedland KE, Carney RM, Duntley SP, Stepanski EJ. Adherence, reports of benefits, and depression among patients treated with continuous positive airway pressure. Psychosomatik Med.69(5), 449–454 (2007).
  • Budhiraja R, Parthasarathy S, Drake CL et al. Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep30(3), 320–324 (2007).
  • Chai CL, Pathinathan A, Smith B. Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea. Cochrane Database Syst. Rev. (4), CD005308 (2006).
  • Nussbaumer Y, Bloch KE, Genser T, Thurnheer R. Equivalence of autoadjusted and constant continuous positive airway pressure in home treatment of sleep apnoea. Chest129(3), 638–643 (2006).
  • Patruno V, Aiolfi S, Costantino G et al. Fixed and auto-adjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea. Chest131, 1393–1399 (2007).
  • Galetke W, Randerath WJ, Stieglitz S et al. Comparison of manual titration and automatic titration based on forced oscillation technique, flow and snoring in obstructive sleep apnea. Sleep Med.10(3), 337–343 (2009).
  • Nolan GM, Doherty LS, McNicholas WT. Auto-adjusting versus fixed positive pressure therapy in mild to moderate obstructive sleep apnoea. Sleep30(2), 189–194 (2007).
  • Morgenthaler TI, Aurora RN, Brown T et al. Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. An American Academy of Sleep Medicine Report. Sleep31(1), 141–147 (2008).
  • Senn O, Brack T, Russi EW, Bloch KE. Continuous positive airway pressure trial as a novel approach to the diagnosis of the obstructive sleep apnoea syndrome. Chest129(1), 67–75 (2006).
  • Garvey JF, McNicholas WT. Continuous positive pressure airway therapy: new generation. Indian J. Med. Res.131, 259–266 (2010).
  • Pépin JL, Borel JL, Janssens JP, Tamisier R, Lévy P. Sleep and Niv: monitoring of the patients under home ventilation. Eur. Respir. Mon.41, 350–366 (2008).
  • Dolan DC, Okonkwo R, Gfullner F, Hansbrough JR, Strobel RJ, Rosenthal L. Longitudinal comparison study of pressure relief (C-Flex) vs. CPAP in OSA patients. Sleep Breath.13(1), 73–77 (2009).
  • Aloia MS, Stanchina M, Arnedt JT, Malhotra A, Millman RP. Treatment adherence and outcomes in flexible vs. standard continuous positive airway pressure therapy. Chest127(6), 2085–2093 (2005).
  • Marshall NS, Neill AM, Campbell AJ. Randomised trial of compliance with flexible (C-Flex) and standard continuous positive airway pressure for severe obstructive sleep apnea. Sleep Breath.12(4), 393–396 (2008).
  • Nilius G, Happel A, Domanski U, Ruhle KH. Pressure-relief continuous positive airway pressure vs. constant continuous positive airway pressure. A comparison of efficacy and compliance. Chest130(4), 1018–1024 (2006).
  • Stepnowsky CJ, Palau JJ, Gifford AL, Ancoli-Israel S. A self-management approach to improving continuous positive airway pressure adherence and outcomes. Behav. Sleep Med.5(2), 131–146 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.